Aldose Reductase Inhibitor, Epalrestat, Reduces Lipid Hydroperoxides in Type 2 Diabetes
Keyword(s):
2010 ◽
Vol 24
(6)
◽
pp. 424-432
◽
2014 ◽
Vol 1
(1)
◽
Keyword(s):
Keyword(s):
2021 ◽
Vol 24
(1)
◽
pp. 337-345
Keyword(s):